Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2008 May 15;111(10):4838-9.
doi: 10.1182/blood-2008-02-139048.

"Regulating" rheumatoid arthritis via autotransplantation

Affiliations
Comment

"Regulating" rheumatoid arthritis via autotransplantation

Steven Z Pavletic et al. Blood. .

Abstract

Using a mouse model of inducible autoimmune arthritis that mimics some aspects of the human disease, Roord and colleagues identify a role for regulatory T cells (Tregs) both for modulation of disease and as a therapeutic component of autologous bone marrow transplantation (aBMT).

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests. ■

Figures

None
Conditioning followed by aBMT leads to a rapid decrease in the severity of arthritis; the clinical effect is reduced by depletion of CD25+ cells. See the complete figure in the article beginning on page 5233.

Comment on

References

    1. Passweg J, Tyndall A. Autologous stem cell transplantation in autoimmune diseases. Semin Hematol. 2007;44:278–285. - PubMed
    1. Johnson BD, Konkol MC, Truitt RL. CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. Biol Blood Marrow Transplant. 2002;8:525–535. - PubMed
    1. June CH, Blazar BR. Clinical application of expanded CD4+25+ cells. Semin Immunol. 2006;18:78–88. - PubMed
    1. Zeiser R, Leveson-Gower DB, Zambricki EA, et al. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood. 2008;111:453–462. - PMC - PubMed
    1. Griffith LM, Pavletic SZ, Tyndall A, et al. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005. Biol Blood Marrow Transplant. 2005;11:862–870. - PubMed